Cargando…
Deficiency of inhibitory TLR4 homolog RP105 exacerbates fibrosis
Activation of TLR4 by its cognate damage-associated molecular patterns (DAMPs) elicits potent profibrotic effects and myofibroblast activation in systemic sclerosis (SSc), while genetic targeting of TLR4 or its DAMPs in mice accelerates fibrosis resolution. To prevent aberrant DAMP/TLR4 activity, a...
Autores principales: | Wang, Wenxia, Bale, Swarna, Yalavarthi, Bharath, Verma, Priyanka, Tsou, Pei-Suen, Calderone, Ken M., Bhattacharyya, Dibyendu, Fisher, Gary J., Varga, John, Bhattacharyya, Swati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675479/ https://www.ncbi.nlm.nih.gov/pubmed/36136452 http://dx.doi.org/10.1172/jci.insight.160684 |
Ejemplares similares
-
Pharmacological inhibition of TAK1 prevents and induces regression of experimental organ fibrosis
por: Bale, Swarna, et al.
Publicado: (2023) -
Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs
por: Wang, Wenxia, et al.
Publicado: (2022) -
Author Correction: Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs
por: Wang, Wenxia, et al.
Publicado: (2023) -
TLR Accessory Molecule RP105 (CD180) Is Involved in Post-Interventional Vascular Remodeling and Soluble RP105 Modulates Neointima Formation
por: Karper, Jacco C., et al.
Publicado: (2013) -
RP105 alleviates myocardial ischemia reperfusion injury via inhibiting TLR4/TRIF signaling pathways
por: Yang, Jun, et al.
Publicado: (2018)